XBiotech Inc

Research XBiotech Inc (XBIT) on Bullrun: market cap USD 71.04M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerXBIT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 71.04M
• Financial periodFY2025
• Net income-USD 45.54M
• Free cash flow-USD 40.21M

Valuation Snapshot

latest market cap is USD 71.04M.

About XBiotech Inc

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation.

Frequently asked questions

What is XBiotech Inc's market cap?

XBiotech Inc's market capitalization is USD 71.04M.

What does XBiotech Inc do?

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases.